Doximity Securities Fraud Class Action
Analysis based on 22 articles · First reported Sep 17, 2026 · Last updated Sep 23, 2026
The lawsuits add legal and reputational overhang to Doximity shares already battered by repeated guidance cuts and slowing growth, keeping downward pressure on investor confidence and valuation. Broader market impact is limited, as the matter is company-specific litigation rather than a systemic regulatory or macroeconomic event.
Multiple investor-rights law firms have filed or announced securities class action lawsuits against Doximity, Inc. (NYSE: DOCS) and certain of its officers, alleging violations of federal securities laws during the Class Period of August 8, 2024 through May 13, 2026. The complaints allege that Doximity overstated the impact of its Newsfeed on revenue growth, was losing market share to competitors with more favorable pricing and engagement models, and relied heavily on banner advertisements and email newsletters rather than deeper engagement tactics, rendering statements about its Newsfeed, revenue growth, market position, engagement, and advertising practices materially false or misleading. The alleged disclosures triggered sharp stock declines: shares fell 13.25% to $54.29 on November 7, 2025 after cautious ad-spending commentary; fell 16.78% to $27.73 on February 6, 2026 after lowered revenue guidance; and fell 23% to $18.01 on May 14, 2026 after missing already-reduced guidance and projecting slower fiscal 2027 growth. Pomerantz LLP, Bronstein, Gewirtz & Grossman, LLC, LLC, and Rosen Law Firm have each issued notices encouraging investors to seek lead plaintiff appointment by the November 16, 2026 deadline. No class has been certified.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard